Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

115
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
115
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

883
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
883
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

668
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
668
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

715
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
715
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central Nervous System Toxoplasmosis is an Under-Recognized Opportunistic infection in Uganda.

Journal of tropical medicine·2026
Same author

Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis.

The Journal of infectious diseases·2026
Same author

Investigation of human leukocyte antigen alleles as risk factors for cryptococcal disease in Ugandan individuals with HIV.

Human immunology·2026
Same author

Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening.

PloS one·2026
Same author

Pulmonary Aspergillosis Treated With Oral Amphotericin B (MAT2203) in a Patient With HIV-Related Cryptococcal Meningitis.

Clinical case reports·2026

Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

1.3K

Cryptococcal Meningitis: Diagnosis and Management Update.

Mahsa Abassi1, David R Boulware2, Joshua Rhein1

  • 1University of Minnesota, Minneapolis, MN, USA ; Infectious Disease Institute, Makerere University, Kampala, Uganda.

Current Tropical Medicine Reports
|August 18, 2015
PubMed
Summary
This summary is machine-generated.

Advances in diagnosing and managing cryptococcal meningitis improve survival. New point-of-care tests and targeted screening, alongside optimal antifungal therapy and intracranial pressure management, enhance patient outcomes.

Keywords:
AIDSAntifungal therapyAntiretroviral therapyCM-IRISCryptococcal meningitisHIVImmune reconstitution inflammatory syndromeReview

More Related Videos

Complementary Use of Microscopic Techniques and Fluorescence Reading in Studying Cryptococcus-Amoeba Interactions
10:56

Complementary Use of Microscopic Techniques and Fluorescence Reading in Studying Cryptococcus-Amoeba Interactions

Published on: June 22, 2019

6.8K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Related Experiment Videos

Last Updated: Apr 5, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

1.3K
Complementary Use of Microscopic Techniques and Fluorescence Reading in Studying Cryptococcus-Amoeba Interactions
10:56

Complementary Use of Microscopic Techniques and Fluorescence Reading in Studying Cryptococcus-Amoeba Interactions

Published on: June 22, 2019

6.8K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Public Health

Background:

  • Cryptococcal meningitis remains a significant cause of mortality, particularly in individuals on antiretroviral therapy (ART).
  • Traditional diagnostic and treatment methods face challenges in resource-limited settings where the disease is most prevalent.

Purpose of the Study:

  • To review recent advancements in the diagnosis and management of cryptococcal meningitis.
  • To highlight cost-effective strategies for reducing mortality.
  • To summarize the efficacy of novel antifungal therapy regimens.

Main Methods:

  • Review of recent clinical trials and therapeutic guidelines.
  • Analysis of diagnostic innovations, including point-of-care testing.
  • Evaluation of management strategies such as targeted screening, antifungal therapy, and intracranial pressure control.

Main Results:

  • Point-of-care testing offers rapid, practical, and affordable diagnosis.
  • Targeted screening for cryptococcal antigenemia is cost-effective in reducing early mortality in patients on ART.
  • Optimal initial management involves amphotericin and flucytosine, though accessibility is limited; therapeutic lumbar punctures and delayed ART initiation improve survival.

Conclusions:

  • Recent advances in diagnostics and management significantly improve survival rates for cryptococcal meningitis.
  • Accessible and cost-effective strategies are crucial for reducing mortality in high-prevalence regions.
  • Ongoing research into novel antifungal combinations holds promise for further improving patient care.